Montelukast Sodium Tablet, Chewable
Product Images NDC 71205-128

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Montelukast Sodium (NDC 71205-128). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure_01 (Montelukast Fig1)

Figure_01 (Montelukast Fig1)
A line graph showing change in height (cm) over weeks on treatment for three groups: Montelukast sodium chewable tablets 5 mg, Beclomethasone 336 mcg, and placebo. The graph plots height changes from approximately -3 to 7 cm over a treatment period extending to 56 weeks, with Montelukast and Beclomethasone groups showing similar height increases compared to placebo.*
FDA Label Image

Figure_2 (Montelukast Fig2)

Figure_2 (Montelukast Fig2)
A line graph comparing the mean percent change from baseline over weeks in treatment between Montelukast sodium tablet and placebo groups. The x-axis represents weeks in treatment from 0 to 13, including a washout period, and the y-axis shows mean percent change from baseline, ranging approximately from 0 to 15. Montelukast sodium shows a higher increase compared to placebo over the treatment period.*
FDA Label Image

Structure (Montelukast Str)

Structure (Montelukast Str)
Chemical structure of montelukast, the active ingredient in MONTELUKAST SODIUM 5 mg chewable tablets. The diagram shows the molecular arrangement including aromatic rings, functional groups, and the sodium salt form.*
FDA Label Image

71205-128-90 (Montelukast 5mg90)

71205-128-90 (Montelukast 5mg90)
Label for Montelukast Sodium 5 mg chewable tablets by Proficient Rx LP. The label states the product is for pediatric patients 6-14 years, each tablet contains 5.2 mg Montelukast Sodium USP equivalent to 5 mg Montelukast. It describes the tablets as pink, circular, slightly mottled, with the code MT2 engraved. The label includes storage instructions and manufacturing details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.